SI
IMGN

Sofinnova Investments’s Immunogen Inc IMGN Stock Holding History

Sofinnova Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,546,902
Closed -$45.9M – 93
2023
Q4 		$45.9M Sell
1,546,902
-498,300
-24% -$9.92M 2.57% 10
2023
Q3 		$32.5M Buy
2,045,202
+1,217,884
+147% +$20.3M 2.05% 18
2023
Q2 		$15.6M Sell
827,318
-97,214
-11% -$1.15M 1.02% 24
2023
Q1 		$3.55M Sell
924,532
-761,622
-45% -$3.25M 0.23% 44
2022
Q4 		$8.36M Buy
1,686,154
+1,183,761
+236% +$6.42M 0.5% 32
2022
Q3 		$2.4M Sell
502,393
-638,395
-56% -$3.37M 0.14% 53
2022
Q2 		$5.13M Sell
1,140,788
-287,381
-20% -$1.25M 0.43% 40
2022
Q1 		$6.8M Sell
1,428,169
-321,713
-18% -$1.78M 0.52% 43
2021
Q4 		$13M Buy
+1,749,882
New +$10.9M 0.76% 37
2019
Q1 		– Sell
-447,075
Closed -$1.94M – 74
2018
Q4 		$2.15M Buy
+447,075
New +$2.71M 0.27% 51

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sofinnova Investments's IMGN Position: Q1 2024 in Review

Sofinnova Investments sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,546,902 shares — an estimated $45.9M sold.

Sofinnova Investments first reported a position in IMGN in Q4 2018 and held it in 10 quarters. The position peaked at $45.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Sofinnova Investments reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Sofinnova Investments sold 1,546,902 Immunogen Inc shares in Q1 2024, an estimated $45.9M.
  • Sofinnova Investments first reported a position in Immunogen Inc in Q4 2018 and held it in 10 quarters.
  • Sofinnova Investments's Immunogen Inc position peaked at $45.9M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Sofinnova Investments's 13F filing for Q1 2024, filed 15 May 2024.